RecruitingPHASE1, PHASE2NCT05384821

Metronomic Chemotherapy in Wilms Tumor (MetroWilms-1906)

Studying Nephroblastoma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Centre Oscar Lambret
Principal Investigator
Hélène SUDOUR-BONNANGE, MD
Centre Oscar Lambret
Intervention
Vincristine(drug)
Enrollment
28 enrolled
Eligibility
17 years · All sexes
Timeline
20222028

Study locations (18)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05384821 on ClinicalTrials.gov

Other trials for Nephroblastoma

Additional recruiting or active studies for the same condition.

See all trials for Nephroblastoma

← Back to all trials